Bank of America’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100
| Closed | -$12.2K | – | 8095 |
|
|
2023
Q3 | $12.2K | Buy |
+100
| New | +$12.7K | ﹤0.01% | 6813 |
|
|
2022
Q1 | – | Sell |
-168,000
| Closed | -$25.6M | – | 8477 |
|
|
2021
Q4 | $25.6M | Buy |
+168,000
| New | +$26M | ﹤0.01% | 1984 |
|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$818K | – | 8230 |
|
|
2021
Q2 | $818K | Sell |
5,000
-79,100
| -94% | -$12.2M | ﹤0.01% | 5055 |
|
|
2021
Q1 | $12.7M | Buy |
84,100
+67,800
| +416% | +$10.8M | ﹤0.01% | 2489 |
|
|
2020
Q4 | $2.47M | Sell |
16,300
-10,200
| -38% | -$1.46M | ﹤0.01% | 3762 |
|
|
2020
Q3 | $3.59M | Hold |
26,500
| – | – | ﹤0.01% | 3214 |
|
|
2020
Q2 | $3.62M | Buy |
26,500
+11,800
| +80% | +$1.5M | ﹤0.01% | 3138 |
|
|
2020
Q1 | $1.58M | Sell |
14,700
-242,700
| -94% | -$27.9M | ﹤0.01% | 3660 |
|
|
2019
Q4 | $31M | Buy |
257,400
+204,000
| +382% | +$22.8M | ﹤0.01% | 1517 |
|
|
2019
Q3 | $5.31M | Sell |
53,400
-155,500
| -74% | -$16.3M | ﹤0.01% | 3143 |
|
|
2019
Q2 | $22.8M | Buy |
208,900
+143,300
| +218% | +$15.2M | ﹤0.01% | 1757 |
|
|
2019
Q1 | $7.33M | Buy |
+65,600
| New | +$7.2M | ﹤0.01% | 2787 |
|
|
2018
Q4 | – | Sell |
-10,200
| Closed | -$1.24M | – | 7215 |
|
|
2018
Q3 | $1.24M | Sell |
10,200
-79,800
| -89% | -$9.4M | ﹤0.01% | 4340 |
|
|
2018
Q2 | $9.88M | Buy |
+90,000
| New | +$9.63M | ﹤0.01% | 2487 |
|
|
2018
Q1 | – | Sell |
-13,500
| Closed | -$1.44M | – | 7200 |
|
|
2017
Q4 | $1.44M | Sell |
13,500
-460,500
| -97% | -$49.2M | ﹤0.01% | 4222 |
|
|
2017
Q3 | $52.7M | Buy |
474,000
+203,400
| +75% | +$21.7M | 0.01% | 1106 |
|
|
2017
Q2 | $28M | Sell |
270,600
-28,500
| -10% | -$2.81M | 0.01% | 1459 |
|
|
2017
Q1 | $29.2M | Buy |
299,100
+298,800
| +99,600% | +$28.6M | 0.01% | 1431 |
|
|
2016
Q4 | $27K | Hold |
300
| – | – | ﹤0.01% | 6211 |
|
|
2016
Q3 | $29K | Sell |
300
-100,200
| -100% | -$9.53M | ﹤0.01% | 5973 |
|
|
2016
Q2 | $8.62M | Buy |
100,500
+10,200
| +11% | +$915K | ﹤0.01% | 2328 |
|
|
2016
Q1 | $7.85M | Buy |
90,300
+65,400
| +263% | +$5.85M | ﹤0.01% | 2369 |
|
|
2015
Q4 | $2.81M | Sell |
24,900
-52,500
| -68% | -$5.7M | ﹤0.01% | 3496 |
|
|
2015
Q3 | $7.83M | Buy |
+77,400
| New | +$9.28M | ﹤0.01% | 2439 |
|
|
2015
Q1 | – | Sell |
-3,900
| Closed | -$394K | – | 7284 |
|
|
2014
Q4 | $394K | Sell |
3,900
-300
| -7% | -$29.2K | ﹤0.01% | 4835 |
|
|
2014
Q3 | $383K | Buy |
4,200
+1,800
| +75% | +$158K | ﹤0.01% | 4829 |
|
|
2014
Q2 | $206K | Sell |
2,400
-452,700
| -99% | -$35.7M | ﹤0.01% | 5532 |
|
|
2014
Q1 | $35.9M | Buy |
455,100
+444,000
| +4,000% | +$37M | 0.01% | 926 |
|
|
2013
Q4 | $840K | Sell |
11,100
-6,900
| -38% | -$490K | ﹤0.01% | 4257 |
|
|
2013
Q3 | $1.26M | Sell |
18,000
-39,000
| -68% | -$2.56M | ﹤0.01% | 3721 |
|
|
2013
Q2 | $3.3M | Buy |
+57,000
| New | +$3.29M | ﹤0.01% | 2671 |
|
Other funds holding IBB
CB
Bank of America's IBB Position: Q1 2026 in Review
Bank of America increased its iShares Biotechnology ETF (IBB) stake by 11% in Q1 2026, buying an estimated $121M and bringing the position to 7,259,501 shares worth $1.23B. The position accounts for 0.09% of the portfolio, ranked #215.
Bank of America first reported a position in IBB in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.08B in Q4 2020. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Bank of America held 7,259,501 shares of iShares Biotechnology ETF worth $1.23B as of Q1 2026.
- Bank of America bought 707,343 iShares Biotechnology ETF shares in Q1 2026, an estimated $121M.
- iShares Biotechnology ETF made up 0.09% of Bank of America's portfolio in Q1 2026, its #215 holding.
- Bank of America first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 52 quarters since.
- Bank of America's iShares Biotechnology ETF position peaked at $2.08B in Q4 2020.
- 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.